![]() |
|
|



* Department of Medicine,
Institute for Cancer Research and
** Institute of Human Nutrition, Columbia University, New York, NY 10032
3To whom correspondence should be addressed. E-mail: wsb2{at}columbia.edu.
| ABSTRACT |
|---|
|
|
|---|
All retinoids must be acquired from the diet either as preformed vitamin A (primarily as retinol and retinyl ester) or as provitamin A carotenoid (usually as
-carotene, ß-carotene or ß-cryptoxanthin) (1,68). Within the small intestine a portion of the provitamin A carotenoid is cleaved by carotene cleavage enzyme (CCE) to retinal and, following its enzymatic conversion to retinyl ester, this carotene-derived retinoid is packaged along with dietary preformed retinoid in nascent chylomicrons (68). Some unconverted dietary provitamin A carotenoid is also incorporated into chylomicrons and absorbed intact (68). The majority of chylomicron retinoid and carotenoid is cleared from the circulation by the liver. However, a significant percentage, 2530%, of chylomicron retinoid is cleared from the circulation by extrahepatic tissues (68).
To meet tissue needs for retinoid, the liver secretes retinol bound to retinol-binding protein (RBP) (911). In the blood, the retinol-RBP complex forms a protein-protein complex with transthyretin (TTR) (911). Blood levels of retinol-RBP-TTR are held relatively constant throughout life except during time of impaired dietary intake of retinoid or in certain disease states (911). In addition to retinol bound to RBP-TTR, other retinoid forms can be found in the fasting circulation, albeit at relatively low levels compared to retinol (911). The fasting circulation contains low levels of all-trans-retinoic acid bound to albumin (at 0.1 to 0.4% of the level of plasma retinol) and soluble retinoyl-ß-glucuronides and retinyl-ß-glucuronides (68). In addition, retinyl esters and provitamin A carotenoids are present in circulating lipoprotein fractions (10,11). These alternative circulating retinoids and their subsequent metabolism within cells are summarized diagramatically in Figure 1.
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
The generation and physiology of RBP-deficient mice have been described in detail elsewhere (13). RBP-deficient and wild type mice from the same genetic background were maintained ad lib on a vitamin A-sufficient commercial chow diet (W.F. Fisher & Son, Piscataway, NJ). All mice were housed throughout life in a specific virus and pathogen free barrier environment in accordance with the NIH guidelines (16).
HPLC analysis of serum and liver vitamin A
Serum retinol and liver total retinol (retinol + retinyl ester) concentrations were determined by reverse-phase HPLC using a procedure we have previously described (17). Briefly, to an aliquot of serum (or liver homogenates) an equal volume of absolute ethanol containing a known amount of the internal standard retinyl acetate (Sigma Chemical Co., St. Louis, MO) was added. Endogenous retinol and retinyl esters and the internal standard were extracted into hexane. After one backwash with H2O, the hexane extract was evaporated to dryness under a gentle stream of N2. Immediately upon reaching dryness, the retinoid containing lipid film was redissolved in 40 µl benzene for injection onto the HPLC. Retinol and retinyl esters were analyzed on a 4.6 x 250 mm 5 µm Beckmann Ultrasphere C18 column (Beckmann Instruments, Fullerton, CA). The mobile phase consisted of acetonitrile/methanol/dichloromethane (70:15:15 v/v) delivered at a flow rate of 1.8 mL/min. Retinoids were detected by UV absorbance at 325 nm using a Waters 996 detector.
Expression and purification of CCE
An open reading frame for a CCE cDNA was amplified by PCR from the original clone (AW044715) and subcloned into the mammalian expression vector pcDNA3 (CCE/pcDNA3) (Invitrogen, San Diego, CA) and into the bacterial expression vector pGEX-3X (CCE/pGEX) (Amersham Pharmacia, Piscataway, NJ) (18). Both clones were sequenced to verify orientation and correct reading frame in the case of the pGEX-3X vector. This latter vector was used to express CCE as a fusion protein with bacterial glutathione-S-transferase (GST). The recombinant fusion protein was purified by affinity chromatography on glutathione-Sepharose (Amersham Pharmacia, Piscataway, NJ), according to the manufacturers instructions. Expression of a GST-containing fusion protein in E. coli was confirmed by Western blot analysis. CCE/pcDNA3 was transfected into CHO cells using calcium-phosphate transfection (19) and CCE expression was verified by Northern blot analysis and in vitro enzyme activity assay.
Assay of CCE activity
In vitro enzyme assays for CCE were carried out using a previously reported procedure (18,20). As an enzyme source, depending on the experiment, we employed either crude bacterial homogenate (CCE/pGEX), 12,000 x g supernatant obtained from the bacterial homogenate, purified GST-fusion protein of carotene cleavage enzyme or 10,000 x g supernatant obtained from CHO cells transfected with carotene cleavage enzyme. Protein concentrations were measured using Bio-Rad Bradford protein assay reagents according to the manufacturers instructions employing bovine serum albumin as standard. Specific activity was defined as pmol of retinal produced/mg protein/h. Enzyme kinetics data were analyzed using EnzFit 5.0 software (Perrella Scientific, Amherst, NH).
Retinal and retinol isomers and ß-carotene were analyzed by normal phase HPLC on a 4.6 x 150 mm Supelcosil LC-Si column (Supelco, St. Louis, MO) preceded by a silica guard column (Supelco) using hexane:ethyl acetate:butanol (96.9:3:0.1, v/v) as the mobile phase flowing at a rate of 0.8 mL/min. Isomers of retinol and retinal, and ß-carotene were detected by absorbance of 325, 365, and 450 nm, respectively, using a Waters 996 Photodiode array detector (Waters Associates, Milford, MA). Retinol and retinal peaks were identified by comparing retention times and spectral data for the experimental compounds with those of authentic standards. Each retinol and retinal isomer was quantitated by comparing its integrated area under the peak against those of known amounts of purified standards. The loss during extraction was accounted for by adjusting the recovery to that of the internal standards, either 13-cis-retinol or all-trans-9-(4-methoxy-2,3,6-trimethyl phenyl)-3,7-dimethyl-2,4,6,8-nonatetraen-101 (TMMP-ROH).
Pull-down assays
Mouse CCE fused to GST was purified using glutathione-Sepharose and incubated with a 10,000 x g supernatant from a mouse testis homogenate for 30 min at room temperature. Following incubation, the mixtures were centrifuged at 500 x g for 5 min at 4°C and unbound proteins were discarded. The testis protein(s) precipitating with the CCE-GST fusion protein bound to the glutathione-Sepharose was considered the pull-down product. The glutathione-Sepharose beads were then washed 3 times with PBS and proteins bound to the glutathione-Sepharose were eluted with 10 mmol/L glutathionine in 50 mmol/L Tris, pH 8.0. Proteins eluting from the affinity resin were separated by 15% SDS-PAGE to identify proteins that interact with the carotene cleavage enzyme fusion protein. Protein bands were subjected to matrix-assisted laser desorption ionization-mass spectrometry (MALDI-MS) by the Protein Chemistry Core Facility of the Howard Hughes Medical Institute at Columbia University (18).
| RESULTS |
|---|
|
|
|---|
Measures of serum retinol levels in the RBP-deficient mice indicate that small amounts of retinol (36 µg/dL) are present in the circulation of the mutant mice fed a control vitamin A-sufficient chow diet (13,14). However, when the RBP-deficient mice are placed on a totally vitamin A-deficient, but otherwise nutritionally complete diet, serum retinol levels quickly (within 6 d) drop to undetectable (13,14). Figure 2 shows the effect of age on hepatic total retinol (retinol + retinyl ester) concentrations for wild type and RBP-deficient mice maintained on a vitamin A-sufficient diet throughout life. As can be seen from Figure 2, at the time of weaning (postnatal days 19, 20 and 21) the wild type and RBP-deficient mice have nearly identical hepatic total retinol levels. However, by 5- and 8-mo of age, the levels of total hepatic retinol in the RBP-deficient mice are elevated compared to wild type controls. Thus, RBP-deficient mice take up dietary vitamin A efficiently. The accumulation of hepatic retinol in the mutants reflects their inability to mobilize hepatic retinol stores.
|
We are interested in understanding how tissues within the body acquire retinoid from the circulation and the recent identification of cDNA clones for CCE (18,2126) has made it possible to explore molecular aspects of the delivery to and metabolism of provitamin A in tissues. Mouse testis expresses the highest levels of CCE mRNA of any tissue in the mouse, including the small intestine (Fig. 3). Since CCE is a soluble enzyme that utilizes highly insoluble hydrocarbons like ß-carotene as substrates, we hypothesized that CCE must act in concert with other cellular proteins if it is to catalyze efficiently ß-carotene cleavage. To this end, we carried out pull-down experiments using mouse testis 10,000 x g supernatants and recombinant mouse CCE-GST fusion protein. An SDS-PAGE gel for a representative pull-down experiment is shown in Figure 4. Of the several protein bands associated with the CCE-GST fusion protein, one with an apparent mass of
32 kDa was a specific pull-down product (Fig. 4). The Coomassie stained band for this protein was removed from the SDS-PAGE gel (see Fig. 4), digested with trypsin and analyzed by MALDI-MS. The protein was identified as a testis specific isoform of lactate dehydrogenase, lactate dehydrogenase-C (LDH-C) (27,28). The MALDI-MS profile for the trypsin fragments and the sizes of predicted trypsin fragments of mouse LDH-C are provided in Figure 5. All 21 tryptic fragments labeled in Figure 5 agree within 0.5 mass-ion units with those predicted from database analysis for mouse LDH-C.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
How are the RBP-deficient mice able to thrive? Neither retinoic acid transport nor retinyl ester transport in the circulations is upregulated. The chow and purified diets that we have employed in our studies of RBP-deficient mice contain no or only very little provitamin A carotenoid. We believe that the RBP-deficient mice are able to acquire sufficient vitamin A from its regular (daily) intake from the diet. Approximately one-quarter of dietary vitamin A is delivered to extrahepatic tissues (68). Since the mutant mice cannot mobilize hepatic retinol stores, it is this delivery of postprandial vitamin A to extrahepatic tissues that renders these mice phenotypically normal. We propose that RBP allows for the storage of dietary vitamin A in the liver and assures that tissues are able continuously to acquire vitamin A from liver stores even in times of insufficient dietary vitamin A intake. The primary function of RBP, therefore, is to relieve the organism of the obligate need for daily vitamin A intake from the diet.
Some provitamin A carotenoids escape cleavage to vitamin A in the intestinal mucosa and are absorbed intact into the body from the diet. It is possible that this provitamin A carotenoid can serve also as an important source of vitamin A in tissues. The recent cloning of CCE in Drosophila (21), chicken (22), mouse (18,24,25) and the human (26) has renewed interest in the biochemistry of tissues utilization of circulating provitamin A carotenoid. Since CCE is expressed in the mouse testis (Fig. 5), this allows the testis to cleave provitamin A carotenoids to vitamin A. Our in vitro studies indicate that mouse CCE can participate in protein-protein interactions with LDH-C. These data may suggest that CCE and LDH-C exist as a complex within the cytosol that acts physiologically to facilitate carotene cleavage. It is possible that other proteins participate in the complex since both CCE and LDH-C are soluble proteins. It remains to be established how insoluble substrates like ß-carotene associate with CCE and how retinal, which also is water insoluble, is removed from the CCE-LDH-C complex following its formation. The cloning of CCE makes it possible to approach these and other important questions regarding the conversion of provitamin A carotenoids.
Our data provide new insights into how the vitamin A needs of tissues throughout the body are satisfied. Although the experimental approaches that we have used for our studies are modern, many of the questions that we addressed are not new. Moreover, many of our findings can be explained and understood using data that have been available in the literature for decades. However, from the context of a memorial symposium honoring Professor James A. Olson, whose work on vitamin A and carotenoids has spanned five decades, this is probably not inappropriate. Ultimately, our investigations are but part of a larger picture that was first framed by Professor Olson and other earlier investigators. This work provides some new glimpses into vitamin A and carotenoid physiology but also reminds us of things these earlier investigators already knew.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 This work was supported by NIH grants R01 EY12858 and R01 DK52444 and a grant from the United States Department of Agriculture. ![]()
4 Abbreviations used: CCE, carotene cleavage enzyme; GST, glutathione-S-transferase; LDH-C, lactate dehydrogenase-C; retinoic acid receptor; MALDI-MS, matrix-assisted laser desorption ionization-mass spectrometry; RAR, retinoic acid receptor; RBP, retinol-binding protein; RXR, retinoid X receptor; TTR, transthyretin. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Goodman, D. S. (1984) Vitamin A and retinoids in health and disease. N. Engl. J. Med. 310:1023-1031.[Medline]
2. Hofmann, C. & Eichele, G. (1994) Retinoids in development. Sporn, M. B. Roberts, A. B. Goodman, D. S. eds. The Retinoids, Biology, Chemistry, and Medicine 1994:387-442 Raven Press New York, NY. .
3. Mangelsdorf, D. M., Umesono, K. & Evans, R. M. (1994) The retinoid receptors. Sporn, M. B. Roberts, A. B. Goodman, D. S. eds. The Retinoids: Biology, Chemistry, and Medicine 1994:319-350 Raven Press New York, NY. .
4. Gudas, L. J., Sporn, M. B. & Roberts, A. B. (1994) Cellular biology and biochemistry of the retinoids. Sporn, M. B. Roberts, A. B. Goodman, D. S. eds. The Retinoids: Biology, Chemistry, and Medicine 1994:443-520 Raven Press New York, NY. .
5. Saari, J. C. (1994) Retinoids in photosensitive systems. Sporn, M. B. Roberts, A. B. Goodman, D. S. eds. The Retinoids: Biology, Chemistry and Medicine 1994:351-386 Raven Press New York, NY. .
6. Goodman, D. S., Huang, H. S. & Shiratori, T. (1965) Tissue distribution and metabolism of newly absorbed vitamin A in the rat. J. Lipid Res. 6:390-396.[Abstract]
7. Blaner, W. S. & Olson, J. A. (1994) Retinol and retinoic acid metabolism. Sporn, M. B. Roberts, A. B. Goodman, D. S. eds. The Retinoids: Biology, Chemistry, and Medicine 1994:229-256 Raven Press New York, NY. .
8. Vogel, S., Gamble, M. V. & Blaner, W. S. (1999) Retinoid uptake, metabolism and transport. Nau, H. Blaner, W. S. eds. The Handbook of Experimental Pharmacology, The Retinoids 1999:31-96 Springer Verlag Heidelberg. .
9. Goodman, D. S. (1984) Plasma retinol-binding protein. Sporn, M. B. Roberts, A. B. Goodman, D. S. eds. The Retinoids 2:41-88 Academic Press Orlando, FL. .
10. Soprano, D. R. & Blaner, W. S. (1994) Plasma retinol-binding protein. Sporn, M. B. Roberts, A. B. Goodman, D. S. eds. The Retinoids, Biology, Chemistry, and Medicine 1994:257-282 Raven Press New York, NY. .
11. Gamble, M. V. & Blaner, W. S. (1999) Factors affecting blood retinol levels of vitamin A. Livrea, M. A. eds. Vitamin A and Retinoids: An Update of Biological Aspects and Clinical Applications (MCBU) 1999:1-18 Birkhauser Publishing Ltd. Basel, Switzerland. .
12. Episkopou, V., Maeda, S., Nishiguchi, S., Shimada, K., Gaitanaris, G. A., Gottesman, M. E. & Robertson, E. J. (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc. Natl. Acad. Sci. U.S.A. 90:2375-2379.
13. Quadro, L., Blaner, W. S., Salchow, D. J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, S., Cosma, M. P., Colantuoni, V. & Gottesman, M. E. (1999) Visual defect and impaired retinoid availability in mice lacking retinol-binding protein. EMBO J. 18:4633-4644.[Medline]
14. Quadro, L., Gamble, M. V., Vogel, S., Lima, A.A.M., Piantedosi, R., Moore, S. R., Colantuoni, V., Gottesman, M. E., Guerrant, R. L. & Blaner, W. S. (2000) Retinol and retinol-binding protein: the immune response and gut integrity. J. Infect. Dis. 182:S97-S102.
15. Kurlandsky, S. B., Gamble, M. V., Ramakrishnan, R. & Blaner, W. S. (1995) Plasma delivery of retinoic acid to tissues in the rat. J. Biol. Chem. 270:17850-17857.
16. U.S. Department of Health and Human Services. (1985) NIH guide for the care and use of laboratory animals 1985 Health Resources and Services Administration Rockville, MD: (NIH Publication) 8523.
17. Wei, S., Episkopou, V., Piantedosi, R., Maeda, S., Shimada, K., Gottesman, M. E. & Blaner, W. S. (1995) Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J. Biol. Chem. 270:886-870.
18. Paik, J., During, A., Harrison, E. H., Mendelsohn, C. L., Lai, K. & Blaner, W. S. (2001) Expression and characterization of a murine enzyme able to cleave ß-carotene: The formation of retinoids. J. Biol. Chem. 276:32160-32168.
19. Miller, A. D., Miller, D. G., Garcia, J. V. & Lynch, C. M. (1993) Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217:581-599.[Medline]
20. During, A., Nagao, A., Hoshino, C. & Terao, J. (1996) Assay of beta-carotene 15,15'-dixoygenase activity by reverse-phase high-pressure liquid chromatography. Anal. Biochem. 241:199-205.[Medline]
21. von Lintig, J. & Vogt, K. (2000) Filling the gap in vitamin A research. Molecular identification of an enzyme cleaving beta-carotene to retinal. J. Biol. Chem. 275:11915-11920.
22. Wyss, A., Wirtz, G., Woggon, W., Brugger, R., Wyss, M., Friedlein, A., Bachmann, H. & Hunziker, W. (2000) Cloning and expression of beta,beta-carotene 15,15'-dioxygenase. Biochem. Biophys. Res. Commun. 271:334-336.[Medline]
23. Wyss, A., Wirtz, G. M., Woggon, W. D., Brugger, R., Wyss, M., Friedlein, A., Riss, G., Bachmann, H. & Hunziker, W. (2001) Expression pattern and localization of beta,beta-carotene 15,15'-dioxygenase in different tissues. Biochem. J. 354:521-529.[Medline]
24. Redmond, T. M., Gentleman, S., Duncan, T., Yu, S., Wiggert, B., Gantt, E. & Cunningham, F. X., Jr (2001) Identification, expression, and substrate specificity of a mammalian beta-carotene 15,15'-dioxygenase. J. Biol. Chem. 276:6560-6565.
25. Yan, W., Jang, G-F., Haeseleer, F., Esumi, N., Chang, J., Kerrigan, M., Campochiaro, M., Campochiaro, P., Palczeqski, K. & Zack, D. J. (2001) Cloning and characterization of human ß,ß-carotene-15,15'-dioxygenase that is highly expressed in the retinal pigment epithelium. Genomics 72:193-202.[Medline]
26. Kiefer, C., Hessel, S., Lampert, J. M., Vogt, K., Lederer, M. O., Breithaupt, D. E. & von Lintig, J. (2001) Identification and characterization of a mammalian enzyme catalyzing the asymmetric oxidative cleavage of provitamin A. J. Biol. Chem. 276:14110-14116.
27. Thomas, K., Del Mazo, J., Eversole, P., Bellve, A., Hiraoka, Y., Li, S. S. & Simon, M. (1990) Developmental regulation of expression of the lactate dehydrogenase (LDH) multigene family during mouse spermatogenesis. Development 109:483-493.[Abstract]
28. Blanco, A., Burgos, C., Gerez de Burgos, N. & M & Montamat, E. E. (1976) Properties of the testicular lactate dehydrogenase isoenzyme. Biochem. J. 153:165-172.[Medline]
This article has been cited by other articles:
![]() |
L. Levi, B. Levavi-Sivan, and E. Lubzens Expression of Genes Associated with Retinoid Metabolism in the Trout Ovarian Follicle Biol Reprod, September 1, 2008; 79(3): 570 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sun, R. L. Surles, and S. A. Tanumihardjo Vitamin A Concentrations in Piglet Extrahepatic Tissues Respond Differently Ten Days after Vitamin A Treatment J. Nutr., June 1, 2008; 138(6): 1101 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. U. Schuster, N. J. Kenyon, and C. B. Stephensen Vitamin A Deficiency Decreases and High Dietary Vitamin A Increases Disease Severity in the Mouse Model of Asthma J. Immunol., February 1, 2008; 180(3): 1834 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L Surles, J. P Mills, A. R Valentine, and S. A Tanumihardjo One-time graded doses of vitamin A to weanling piglets enhance hepatic retinol but do not always prevent vitamin A deficiency Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1045 - 1053. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||